Literature DB >> 25267199

OVOL2 is a critical regulator of ER71/ETV2 in generating FLK1+, hematopoietic, and endothelial cells from embryonic stem cells.

Ju Young Kim1, Ra Ham Lee2, Tae Min Kim3, Dong-Wook Kim2, Young-Joo Jeon2, Sung-Ho Huh4, Se-Yeong Oh5, Michael Kyba6, Hiroshi Kataoka7, Kyunghee Choi8, David M Ornitz4, Jung-Il Chae2, Changwon Park1.   

Abstract

In this study, we report that OVOL2, a C2H2 zinc finger protein, is a novel binding protein of ER71, which is a critical transcription factor for blood and vessel development. OVOL2 directly interacted with ER71, but not with ETS1 or ETS2, in the nucleus. ER71-mediated activation of the Flk1 promoter was further enhanced by OVOL2, although OVOL2 alone failed to activate it. Consistently, coexpression of ER71 and OVOL2 in differentiating embryonic stem cells led to a significant augmentation of FLK1(+), endothelial, and hematopoietic cells. Such cooperative effects were impaired by the short hairpin RNA-mediated inhibition of Ovol2. Collectively, we show that ER71 directly interacts with OVOL2 and that such interaction is critical for FLK1(+) cell generation and their differentiation into downstream cell lineages.
© 2014 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25267199      PMCID: PMC4224193          DOI: 10.1182/blood-2014-03-556332

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

Review 1.  The ETS-domain transcription factor family.

Authors:  A D Sharrocks
Journal:  Nat Rev Mol Cell Biol       Date:  2001-11       Impact factor: 94.444

2.  Cooperative interaction of hypoxia-inducible factor-2alpha (HIF-2alpha ) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1).

Authors:  Gerd Elvert; Andreas Kappel; Regina Heidenreich; Ursula Englmeier; Stephan Lanz; Till Acker; Manuel Rauter; Karl Plate; Michael Sieweke; Georg Breier; Ingo Flamme
Journal:  J Biol Chem       Date:  2002-12-02       Impact factor: 5.157

3.  ER71 specifies Flk-1+ hemangiogenic mesoderm by inhibiting cardiac mesoderm and Wnt signaling.

Authors:  Fang Liu; Inyoung Kang; Changwon Park; Li-Wei Chang; Wei Wang; Dongjun Lee; Dae-Sik Lim; Daniel Vittet; Jeanne M Nerbonne; Kyunghee Choi
Journal:  Blood       Date:  2012-02-17       Impact factor: 22.113

Review 4.  Hemogenic endothelium during development and beyond.

Authors:  Karen K Hirschi
Journal:  Blood       Date:  2012-03-13       Impact factor: 22.113

5.  Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1.

Authors:  Y Fujiwara; C P Browne; K Cunniff; S C Goff; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

6.  The zinc finger transcription factor Ovol2 acts downstream of the bone morphogenetic protein pathway to regulate the cell fate decision between neuroectoderm and mesendoderm.

Authors:  Ting Zhang; Qingqing Zhu; Zhihui Xie; Yongfeng Chen; Yunbo Qiao; Lingyu Li; Naihe Jing
Journal:  J Biol Chem       Date:  2013-01-14       Impact factor: 5.157

7.  Cloning of the murine ER71 gene (Etsrp71) and initial characterization of its promoter.

Authors:  Luciano De Haro; Ralf Janknecht
Journal:  Genomics       Date:  2005-04       Impact factor: 5.736

8.  Role of SCL/Tal-1, GATA, and ets transcription factor binding sites for the regulation of flk-1 expression during murine vascular development.

Authors:  A Kappel; T M Schlaeger; I Flamme; S H Orkin; W Risau; G Breier
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

9.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.

Authors:  F Shalaby; J Rossant; T P Yamaguchi; M Gertsenstein; X F Wu; M L Breitman; A C Schuh
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

10.  Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele.

Authors:  P Carmeliet; V Ferreira; G Breier; S Pollefeyt; L Kieckens; M Gertsenstein; M Fahrig; A Vandenhoeck; K Harpal; C Eberhardt; C Declercq; J Pawling; L Moons; D Collen; W Risau; A Nagy
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

View more
  14 in total

1.  Induction of hematopoietic and endothelial cell program orchestrated by ETS transcription factor ER71/ETV2.

Authors:  Fang Liu; Daofeng Li; Yik Yeung Lawrence Yu; Inyoung Kang; Min-Ji Cha; Ju Young Kim; Changwon Park; Dennis K Watson; Ting Wang; Kyunghee Choi
Journal:  EMBO Rep       Date:  2015-03-23       Impact factor: 8.807

2.  Feedback Mechanisms Regulate Ets Variant 2 (Etv2) Gene Expression and Hematoendothelial Lineages.

Authors:  Naoko Koyano-Nakagawa; Xiaozhong Shi; Tara L Rasmussen; Satyabrata Das; Camille A Walter; Daniel J Garry
Journal:  J Biol Chem       Date:  2015-09-22       Impact factor: 5.157

3.  Direct Reprogramming of Human Dermal Fibroblasts Into Endothelial Cells Using ER71/ETV2.

Authors:  Sangho Lee; Changwon Park; Ji Woong Han; Ju Young Kim; Kyuwon Cho; Eun Jae Kim; Sangsung Kim; Shin-Jeong Lee; Se Yeong Oh; Yoshiaki Tanaka; In-Hyun Park; Hyo Jae An; Claire Min Shin; Shraya Sharma; Young-Sup Yoon
Journal:  Circ Res       Date:  2016-12-21       Impact factor: 17.367

Review 4.  Differentiation of pluripotent stem cells into endothelial cells.

Authors:  Mervin C Yoder
Journal:  Curr Opin Hematol       Date:  2015-05       Impact factor: 3.284

Review 5.  Etv2 as an essential regulator of mesodermal lineage development.

Authors:  Naoko Koyano-Nakagawa; Daniel J Garry
Journal:  Cardiovasc Res       Date:  2017-09-01       Impact factor: 10.787

6.  [Aplastic anemia: Current state of diagnosis and treatment].

Authors:  H Schrezenmeier; S Körper; B Höchsmann
Journal:  Internist (Berl)       Date:  2015-09       Impact factor: 0.743

Review 7.  The ETS Factor, ETV2: a Master Regulator for Vascular Endothelial Cell Development.

Authors:  Se-Yeong Oh; Ju Young Kim; Changwon Park
Journal:  Mol Cells       Date:  2015-12-21       Impact factor: 5.034

8.  Shavenbaby and Yorkie mediate Hippo signaling to protect adult stem cells from apoptosis.

Authors:  Jérôme Bohère; Alexandra Mancheno-Ferris; Sandy Al Hayek; Jennifer Zanet; Philippe Valenti; Kohsuke Akino; Yuya Yamabe; Sachi Inagaki; Hélène Chanut-Delalande; Serge Plaza; Yuji Kageyama; Dani Osman; Cédric Polesello; François Payre
Journal:  Nat Commun       Date:  2018-11-30       Impact factor: 14.919

9.  Renal Ischemia-Reperfusion Injury in a Diabetic Monkey Model and Therapeutic Testing of Human Bone Marrow-Derived Mesenchymal Stem Cells.

Authors:  Kyo Won Lee; Tae Min Kim; Kyeong Sik Kim; Seunghwan Lee; Junhun Cho; Jae Berm Park; Ghee Young Kwon; Sung Joo Kim
Journal:  J Diabetes Res       Date:  2018-08-01       Impact factor: 4.011

10.  Cooperation between ETS variant 2 and Jumonji domain‑containing 2 histone demethylases.

Authors:  Xiaomeng Li; Gene Moon; Sook Shin; Bin Zhang; Ralf Janknecht
Journal:  Mol Med Rep       Date:  2018-01-26       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.